Why Is Congress Moving To Ban The Hemp Products That Saved My Son’s Life? (Op-Ed)
“Congress is poised to re-criminalize this plant and again put hundreds of thousands of patients, and the people that love them, in jeopardy.” By Amy Dawn Bourlon-Hilterbran, Moms Mobilized Before my son, Austin, was even five years old, he had been prescribed a series of pharmaceuticals for his epilepsy—opioids, benzodiazepines, rufinamide and more. That continued […]
The Cannabis Industry Is Sleeping On Threat To Repeal Legalization In Maine And Massachusetts (Op-Ed)
“The industry can’t afford to sit this out… National trade groups, operators and investors should help fund and coordinate local opposition now.” By Joanne Caceres and Hannah King, Dentons Two under-the-radar signature drives in New England could become the biggest political test for cannabis legalization in a decade—and the industry is largely ignoring them. In […]
New Jersey Gubernatorial Candidates Need To Step Up For Cannabis Consumers (Op-Ed)
“New Jersey’s cannabis consumers have a list of specific issues that Sherrill and Ciattarelli could address… And we vote—so the candidates would do well to stop by and say ‘high’ to us before Election Day.” By Chris Goldstein, NORML The Garden State is having a quiet economic revolution with legal cannabis, but both mainstream candidates […]
OpEd: Dear California, This Isn’t Legalization
In this powerful speech, industry leader Ben Larson critiques California’s restrictive cannabis policies and calls for smarter, more inclusive legalization that protects access to both regulated cannabis and innovative hemp-derived products. Last week, at the newly minted IgniteIt (formerly Benzinga Cannabis) California Market Spotlight, I was invited to read a letter I had written to Gavin […]
What Cannabis Companies Need To Know About Work-Related Asthma (Op-Ed)
“The cannabis industry’s unique exposures and the documented health concerns are likely to accelerate regulatory action and litigation risk.” By Erin Bass, Amy Rubenstein and Julie Vanneman, Dentons The legal cannabis industry employs more than 440,000 full-time workers across the United States (not including hemp industry employees). As legalization spreads, so do regulatory and workplace […]
What Will Marijuana Rescheduling Mean For Hemp, Which Is Already Fully Descheduled? (Op-Ed)
“Increased acceptance and understanding could drive greater consumer demand and foster more mainstream integration of hemp-derived products into appropriate regulated frameworks.” By Shawn Hauser, Vicente LLP The Drug Enforcement Administration’s (DEA) pending reclassification of marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA) marks a historic and long-overdue milestone in U.S. […]